Atopic Dermatitis Research Network – Clinical Research Centers
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute of Allergy and Infectious Diseases (NIAID) is continuing its support for the Atopic Dermatitis Research Network (ADRN) program, aimed at advancing knowledge in skin immunology and defense mechanisms. This initiative funds research centers nationwide that conduct interdisciplinary and translational studies focusing on the differences in skin immune responses, structure, and function between individuals with atopic dermatitis and healthy controls. The program also facilitates single-site pilot trials or observational studies and promotes opportunities for junior investigators to develop their research skills and independence. This effort is authorized under Sections 301 and 405 of the Public Health Service Act and relevant federal regulations, ensuring structured governance and compliance. The contract is forecasted by the National Institutes of Health within the Department of Health and Human Services, with the primary point of contact being Dr. Michael Minnicozzi. While specific details such as solicitation number or place of performance remain unspecified, the program’s goal is to foster innovative research collaborations and support emerging investigators in the field of atopic dermatitis.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the Atopic Dermatitis Research Network (ADRN) program. This program will support research centers across the United States conducting interdisciplinary and translational research to further improve our understanding of skin immunology and defense mechanisms by focusing on differences between individuals with atopic dermatitis and healthy controls in skin immune responses, structure, and function. Also supported under the ADRN is the conduct of single site pilot trials or observational studies and opportunities for junior investigators to build a research background and foster independence. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
